Nuvalent, Inc. · 8 hours ago
Senior Counsel, Commercial
United States
Full-time
Remote
Senior Level
$240K/yr - $270K/yr
7+ years expNuvalent, Inc. is an early-stage company focused on developing selective medicines for cancer treatment. The Senior Counsel, Commercial will provide legal advisement on various strategic issues related to the commercialization of prescription drug products, including compliance with healthcare laws and FDA regulations.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Serve as a legal advisor on a broad range of commercialization-related subjects in support of anticipated launch of company’s first oncology product to the cross functional brand team, including marketing, medical affairs, market access, sales, and other key stakeholders
Serve as an experienced subject matter expert and review committee member for advertising, promotional and non-promotional materials, and medical materials, including sales and marketing materials, market access materials, patient support program information, disease education, scientific exchange, press releases, and clinical trial recruitment activities
Provide legal advisement on the design and implementation of sales and marketing strategy, market access activities, patient support programs, medical affairs initiatives, media campaigns, and interactions with patients and patient advocacy organizations
Provide ad-hoc advice on contracts with health care fraud and abuse, FDA or brand related implications
Advise on commercialization-related contracts and engagements, including, vendor agreements, service agreements, consulting agreements, statements of work, and sponsorships
Serve as a legal representative on cross functional project teams, as assigned, to support business initiatives, identify and mitigate legal risks and to foster collaboration across other legal and compliance disciplines as appropriate
Assist in the development of the enterprise-wide compliance program
Additional responsibilities as assigned
Qualification
Required
7+ years of recent relevant legal experience in product support of biotech/pharma, with a strong preference for experience with launching a product in the U.S. market and 3+ years in-house pharmaceutical or biotech oncology experience
Juris Doctor from an accredited law school; active membership and in good standing in a state bar and either admitted to the Massachusetts bar or eligible for admission to the Massachusetts bar as in-house counsel
Significant knowledge of enforcement trends, the Federal Food, Drug and Cosmetic Act and related regulations, the False Claims Act, laws related to fraud and abuse in the life science/biotech/pharma industries, transparency laws, and the PhRMA Code
Experience as the legal representative on a promotional review committee and a medical materials review committee in the pharmaceutical industry
Experience in advising on healthcare fraud and abuse laws
Experience advising on matters governed by FDA regulations
Experience advising on patient support programs and market access initiatives
Ability to provide responsive, thoughtful, pragmatic and clear advice in support of business
Clear communication style that effectively conveys advice and recommendations to key stakeholders
Experience thriving in a fast-paced environment with a solutions-oriented approach
A demonstrated track record of acting with integrity and a collegial, solution-oriented mindset
A champion of a positive and respectful company culture
Team player with strong and effective collaboration and communication skills
Ability to travel as required to support business activities
Preferred
Familiarity with ex-US frameworks (e.g., EFPIA, GDPR) preferred
Experience with pharmaceutical/biotech commercial contracting preferred
Benefits
Medical, dental, and vision insurance
401(k) retirement savings plan
Generous paid time off (including a summer and winter company shutdown)
Company
Nuvalent, Inc.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.82BKey Investors
Bain Capital Life SciencesDeerfield
2025-11-18Post Ipo Secondary· $500M
2024-09-16Post Ipo Equity· $575M
2023-10-16Post Ipo Equity· $300M
Leadership Team
James Porter
CEO
Alexandra Balcom
Chief Financial Officer
Recent News
MarketScreener
2025-12-16
Company data provided by crunchbase